The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Peyer James since 2021.
This trader's CIK number is 1843594.
At the time of last reporting, Peyer James was the Officer of Sensei Biotherapeutics, Inc.. (stock ticker symbol SNSE).
Also see all insider trading activities at Sensei Biotherapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | SNSE | 313,703 | $1,461,628 | 0 | $0 | 0 | $0 |
| 2021 | SNSE | 227,748 | $2,550,035 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-02 | SNSE | Buy | 1,203 | 3.20 | 3,849 |
| 2022-02-28 | SNSE | Buy | 42 | 3.60 | 151 |
| 2022-03-01 | SNSE | Buy | 2,458 | 3.60 | 8,848 |
| 2022-02-25 | SNSE | Buy | 2,500 | 3.65 | 9,125 |
| 2022-02-23 | SNSE | Buy | 2,500 | 3.80 | 9,500 |
| 2022-02-24 | SNSE | Buy | 15,000 | 3.63 | 54,450 |
| 2022-02-18 | SNSE | Buy | 15,000 | 3.97 | 59,550 |
| 2022-02-17 | SNSE | Buy | 4,949 | 4.17 | 20,637 |
| 2022-02-14 | SNSE | Buy | 10,000 | 4.18 | 41,800 |
| 2022-02-16 | SNSE | Buy | 2,551 | 4.25 | 10,841 |
| 2022-02-10 | SNSE | Buy | 5,000 | 4.58 | 22,900 |
| 2022-02-11 | SNSE | Buy | 12,500 | 4.40 | 55,000 |
| 2022-02-04 | SNSE | Buy | 2,500 | 4.45 | 11,125 |
| 2022-02-03 | SNSE | Buy | 17,500 | 4.65 | 81,375 |
| 2022-02-08 | SNSE | Buy | 10,000 | 4.33 | 43,300 |
| 2022-01-27 | SNSE | Buy | 6,100 | 4.31 | 26,290 |
| 2022-01-28 | SNSE | Buy | 8,900 | 4.22 | 37,558 |
| 2022-01-25 | SNSE | Buy | 20,100 | 4.86 | 97,686 |
| 2022-01-26 | SNSE | Buy | 29,900 | 4.62 | 138,138 |
| 2022-01-21 | SNSE | Buy | 24,703 | 4.94 | 122,032 |
| 2022-01-24 | SNSE | Buy | 22,707 | 4.69 | 106,495 |
| 2022-01-19 | SNSE | Buy | 10,244 | 4.97 | 50,912 |
| 2022-01-20 | SNSE | Buy | 20,000 | 5.17 | 103,400 |
| 2022-01-18 | SNSE | Buy | 10,000 | 5.08 | 50,800 |
| 2022-01-13 | SNSE | Buy | 19,953 | 5.13 | 102,358 |
| 2022-01-14 | SNSE | Buy | 6,219 | 4.99 | 31,032 |
| 2022-01-11 | SNSE | Buy | 10,845 | 5.18 | 56,177 |
| 2022-01-12 | SNSE | Buy | 9,202 | 5.22 | 48,034 |
| 2022-01-10 | SNSE | Buy | 10,000 | 5.28 | 52,800 |
| 2021-12-30 | SNSE | Buy | 1,127 | 4.85 | 5,465 |
| 2021-12-29 | SNSE | Buy | 69,000 | 4.98 | 343,620 |
| 2021-12-28 | SNSE | Buy | 11,288 | 5.28 | 59,600 |
| 2021-12-27 | SNSE | Buy | 3,712 | 5.30 | 19,673 |
| 2021-12-23 | SNSE | Buy | 11,000 | 5.27 | 57,969 |
| 2021-12-17 | SNSE | Buy | 117 | 5.29 | 618 |
| 2021-12-16 | SNSE | Buy | 10,925 | 5.25 | 57,356 |
| 2021-05-05 | SNSE | Buy | 350 | 12.00 | 4,200 |
| 2021-04-19 | SNSE | Buy | 1,965 | 13.38 | 26,291 |
| 2021-04-13 | SNSE | Buy | 2,000 | 14.00 | 28,000 |
| 2021-04-07 | SNSE | Buy | 2,000 | 14.00 | 28,000 |
| 2021-04-01 | SNSE | Buy | 1,000 | 14.00 | 14,000 |
| 2021-03-30 | SNSE | Buy | 2,000 | 12.00 | 24,000 |
| 2021-03-24 | SNSE | Buy | 3,750 | 14.12 | 52,950 |
| 2021-03-23 | SNSE | Buy | 10,000 | 14.34 | 143,400 |
| 2021-03-22 | SNSE | Buy | 2,183 | 15.02 | 32,788 |
| 2021-03-18 | SNSE | Buy | 817 | 15.25 | 12,459 |
| 2021-03-08 | SNSE | Buy | 1,000 | 15.25 | 15,249 |
| 2021-03-05 | SNSE | Buy | 8,000 | 13.75 | 110,000 |
| 2021-03-03 | SNSE | Buy | 3,000 | 15.85 | 47,550 |
| 2021-03-04 | SNSE | Buy | 2,000 | 14.12 | 28,250 |
| 2021-03-02 | SNSE | Buy | 3,000 | 16.25 | 48,750 |
| 2021-02-26 | SNSE | Buy | 5,000 | 16.25 | 81,250 |
| 2021-02-24 | SNSE | Buy | 19,000 | 17.63 | 334,970 |
| 2021-02-25 | SNSE | Buy | 12,000 | 15.79 | 189,480 |
| 2021-02-23 | SNSE | Buy | 20,300 | 17.57 | 356,671 |
| 2021-02-22 | SNSE | Buy | 9,802 | 18.88 | 185,061 |
| 2021-02-19 | SNSE | Buy | 11,786 | 19.77 | 233,009 |
| 2021-02-18 | SNSE | Buy | 753 | 19.75 | 14,871 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Peyer James (Officer of Sensei Biotherapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.